                               SEQUENCE LISTING



<110> ICHOR BIOLOGICS, LLC

      UNIVERSIDAD DE CONCEPCION

 

<120> ANTIBODIES TO ANDES HANTAVIRUS, AND METHODS FOR USING SAME



<130> ICHOR-2PCT



<140> PCT/US2018/023483 

<141> 2018-03-21



<150> 62/639,008

<151> 2018-03-06



<150> 62/474,681

<151> 2017-03-22



<160> 20    



<170> PatentIn version 3.5



<210> 1

<211> 373

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      polynucleotide



<400> 1

agaggtgcag ctggtgcagt ctggggctga actaaaaaag cctgggtctt cggtcaaggt       60



ctcctgcaag gcttccggag gcaccttcgt cggctatggt gtcagctggg tgcgacaggt      120



ccccggacat ggacctgagt ggatgggagg attcagccct atctccaata ctgcaaacta      180



tgcagagagg ttccagggca gagtcacgat gatcgtggac ggatccacga gcacagccta      240



catggaactg cgaagcctga gatctgagga cacggccata tattattgtg cgagatcttg      300



cgacttctgg aatgcctatt acaacaattg gttcgacccc tggggccagg gaaccctggt      360



cactgtctcc tca                                                         373





<210> 2

<211> 124

<212> PRT

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      polypeptide



<400> 2

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Leu Lys Lys Pro Gly Ser 

1               5                   10                  15      





Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Val Gly Tyr 

            20                  25                  30          





Gly Val Ser Trp Val Arg Gln Val Pro Gly His Gly Pro Glu Trp Met 

        35                  40                  45              





Gly Gly Phe Ser Pro Ile Ser Asn Thr Ala Asn Tyr Ala Glu Arg Phe 

    50                  55                  60                  





Gln Gly Arg Val Thr Met Ile Val Asp Gly Ser Thr Ser Thr Ala Tyr 

65                  70                  75                  80  





Met Glu Leu Arg Ser Leu Arg Ser Glu Asp Thr Ala Ile Tyr Tyr Cys 

                85                  90                  95      





Ala Arg Ser Cys Asp Phe Trp Asn Ala Tyr Tyr Asn Asn Trp Phe Asp 

            100                 105                 110         





Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 

        115                 120                 





<210> 3

<211> 380

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      polynucleotide



<400> 3

tcctgggccc agtctgccct gactcagcct gcctccgtgt ctgggtctcc tggacagtcg       60



atcaccatct cctgcactgg gaccagcagt gactttgctg attataattc tgtctcttgg      120



taccaacaac acccaggcaa agcccccaaa ctcctgattt ttgatgtcaa tgatcggccc      180



tcaggggttt ctcatcgctt ctctggctcc aagtctggca acacggcctc cctgaccatc      240



tctgggctcc aggctgaaga cgagtctgac tattactgca cctcatatac catctgcaat      300



tcttatgtct tcgggactgg gaccaaggtc accgtcctag gtcagcccaa ggccaacccc      360



actgtccctc tgttcccacc                                                  380





<210> 4

<211> 127

<212> PRT

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      polypeptide



<400> 4

Ser Trp Ala Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser 

1               5                   10                  15      





Pro Gly Gln Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Phe 

            20                  25                  30          





Ala Asp Tyr Asn Ser Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala 

        35                  40                  45              





Pro Lys Leu Leu Ile Phe Asp Val Asn Asp Arg Pro Ser Gly Val Ser 

    50                  55                  60                  





His Arg Phe Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile 

65                  70                  75                  80  





Ser Gly Leu Gln Ala Glu Asp Glu Ser Asp Tyr Tyr Cys Thr Ser Tyr 

                85                  90                  95      





Thr Ile Cys Asn Ser Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val 

            100                 105                 110         





Leu Gly Gln Pro Lys Ala Asn Pro Thr Val Pro Leu Phe Pro Pro 

        115                 120                 125         





<210> 5

<211> 373

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      polynucleotide



<400> 5

acaggtgcag ctgcaggagt cggggggagg cttagttcag cctggggggt ccctgagact       60



ctcctgtgca gcctctggag tcaccttcag cagatactgg atgcactggg tccgccaagc      120



tccaggaaag gggctggtgt gggtcgctgg tgttaatagt gatgggagta gcagaacgta      180



cgcggactct gtgaagggcc gactcaccat ctccagagac aacgccaaga atacggtgtc      240



tctacaaatg gaaagtctga gagtcgacga cacggctcta tatttttgtg tgagcggcat      300



gacggttttt ggaatgatca ggcctcaggt ttttcatgtg tggggccaag ggacaatggt      360



caccgtctct tca                                                         373





<210> 6

<211> 124

<212> PRT

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      polypeptide



<400> 6

Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 

1               5                   10                  15      





Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Val Thr Phe Ser Arg Tyr 

            20                  25                  30          





Trp Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Val Trp Val 

        35                  40                  45              





Ala Gly Val Asn Ser Asp Gly Ser Ser Arg Thr Tyr Ala Asp Ser Val 

    50                  55                  60                  





Lys Gly Arg Leu Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Val Ser 

65                  70                  75                  80  





Leu Gln Met Glu Ser Leu Arg Val Asp Asp Thr Ala Leu Tyr Phe Cys 

                85                  90                  95      





Val Ser Gly Met Thr Val Phe Gly Met Ile Arg Pro Gln Val Phe His 

            100                 105                 110         





Val Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 

        115                 120                 





<210> 7

<211> 383

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      polynucleotide



<400> 7

tcctgggccc agtctgtgct gactcagccg ccctcagtct ctggggcccc agggcagagc       60



gtcaccatct cctgcactgg aaccagctcc aacatcgggg caggttatga tgtacactgg      120



taccagcaac ttgcaggaac agcccccaaa ctcctcatct atgttaacag cgatcggccc      180



tcaggggtcc ctgaccgatt ctctggctcc aagtctggca cctcagcctc cctggccatc      240



actgggctcc aggctgagga cgagggtgac tattactgcc agtcctatga cagcagcctg      300



agtgctgtcg tattcggcgg agggaccaag ttgaccgtcc tacgtcagcc caaggctgcc      360



ccctcggtca ctctgttccc acc                                              383





<210> 8

<211> 128

<212> PRT

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      polypeptide



<400> 8

Ser Trp Ala Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala 

1               5                   10                  15      





Pro Gly Gln Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asn Ile 

            20                  25                  30          





Gly Ala Gly Tyr Asp Val His Trp Tyr Gln Gln Leu Ala Gly Thr Ala 

        35                  40                  45              





Pro Lys Leu Leu Ile Tyr Val Asn Ser Asp Arg Pro Ser Gly Val Pro 

    50                  55                  60                  





Asp Arg Phe Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile 

65                  70                  75                  80  





Thr Gly Leu Gln Ala Glu Asp Glu Gly Asp Tyr Tyr Cys Gln Ser Tyr 

                85                  90                  95      





Asp Ser Ser Leu Ser Ala Val Val Phe Gly Gly Gly Thr Lys Leu Thr 

            100                 105                 110         





Val Leu Arg Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro 

        115                 120                 125             





<210> 9

<211> 18

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      oligonucleotide



<400> 9

gtcggctatg gtgtcagc                                                     18





<210> 10

<211> 39

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      oligonucleotide



<400> 10

tggatgggag gattcagccc tatctccaat actgcaaac                              39





<210> 11

<211> 48

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      oligonucleotide



<400> 11

gcgagatctt gcgacttctg gaatgcctat tacaacaatt ggttcgac                    48





<210> 12

<211> 30

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      oligonucleotide



<400> 12

tttgctgatt ataattctgt ctcttggtac                                        30





<210> 13

<211> 30

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      oligonucleotide



<400> 13

ctcctgattt ttgatgtcaa tgatcggccc                                        30





<210> 14

<211> 27

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      oligonucleotide



<400> 14

acctcatata ccatctgcaa ttcttat                                           27





<210> 15

<211> 18

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      oligonucleotide



<400> 15

agcagatact ggatgcac                                                     18





<210> 16

<211> 36

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      oligonucleotide



<400> 16

tgggtcgctg gtgttaatag tgatgggagt agcaga                                 36





<210> 17

<211> 46

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      oligonucleotide



<400> 17

gagcggcatg acggtttttg gaatgatcag gcctcaggtt tttcat                      46





<210> 18

<211> 27

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      oligonucleotide



<400> 18

atcggggcag gttatgatgt acactgg                                           27





<210> 19

<211> 30

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      oligonucleotide



<400> 19

ctcctcatct atgttaacag cgatcggccc                                        30





<210> 20

<211> 33

<212> DNA

<213> Artificial Sequence



<220>

<223> Description of Artificial Sequence: Synthetic

      oligonucleotide



<400> 20

cagtcctatg acagcagcct gagtgctgtc gta                                    33





